Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
Monogenic Primary Immunodeficiency Disorder Associated With Common Variable Immunodeficiency and Autoimmunity Publisher Pubmed



Asgardoon MH1 ; Azizi G2 ; Yazdani R1, 3 ; Sohani M1 ; Pashangzadeh S1 ; Kalantari A4 ; Shariat M5 ; Shafiei A6 ; Salami F1 ; Jamee M2 ; Rasouli SE2 ; Mohammadi J7 ; Hassanpour G8 ; Tavakol M2 Show All Authors
Authors
  1. Asgardoon MH1
  2. Azizi G2
  3. Yazdani R1, 3
  4. Sohani M1
  5. Pashangzadeh S1
  6. Kalantari A4
  7. Shariat M5
  8. Shafiei A6
  9. Salami F1
  10. Jamee M2
  11. Rasouli SE2
  12. Mohammadi J7
  13. Hassanpour G8
  14. Tavakol M2
  15. Chavoshzadeh Z9
  16. Mahdaviani SA10
  17. Momen T11
  18. Behniafard N12
  19. Nabavi M13
  20. Bemanian MH13
  21. Arshi S13
  22. Molatefi R14
  23. Sherkat R15
  24. Shirkani A16
  25. Alyasin S17
  26. Jabbariazad F18
  27. Ghaffari J19
  28. Mesdaghi M20
  29. Ahanchian H18
  30. Khoshkhui M18
  31. Eslamian MH21
  32. Cheraghi T22
  33. Dabbaghzadeh A23
  34. Nasiri Kalmarzi R24
  35. Esmaeilzadeh H17
  36. Tafaroji J25
  37. Khalili A26
  38. Sadeghishabestari M27
  39. Darougar S9
  40. Moghtaderi M17
  41. Ahmadiafshar A28
  42. Shakerian B29
  43. Heidarzadeh M30
  44. Ghalebaghi B22
  45. Fathi SM31
  46. Darabi B32
  47. Fallahpour M13
  48. Mohsenzadeh A33
  49. Ebrahimi S34
  50. Sharafian S34
  51. Vosughimotlagh A34
  52. Tafakoridelbari M34
  53. Rahimi Hajiabadi M34
  54. Ashournia P34
  55. Razaghian A34
  56. Rezaei A1
  57. Delavari S1
  58. Shirmast P1
  59. Babaha F1
  60. Samavat A35
  61. Mamishi S36
  62. Khazaei HA37
  63. Negahdari B38
  64. Rezaei N1
  65. Abolhassani H3, 39, 40
  66. Aghamohammadi A1, 3

Source: International Archives of Allergy and Immunology Published:2020


Abstract

Background: Common variable immunodeficiency (CVID) is the most frequent primary immunodeficiency disorder mainly characterized by recurrent bacterial infections besides other immunological defects including loss of or dysfunction of B cells and decreased immunoglobulin levels. In this study, our aim is to evaluate clinical, immunological, and molecular data of patients with a primary clinical diagnosis of CVID and autoimmune phenotype with a confirmed genetic diagnosis. Methods: Among 297 patients with CVID, who were registered in the Iranian Primary Immunodeficiency Registry at Children's Medical Center Hospital in Iran, 83 patients have been genetically examined and 27 patients with autoimmunity and confirmed genetic mutations were selected for analysis. Whole-exome sequencing and confirmatory Sanger sequencing methods were used for the study population. A questionnaire was retrospectively filled for all patients to evaluate demographic, laboratory, clinical, and genetic data. Results: In the 27 studied patients, 11 different genetic defects were identified, and the most common mutated gene was LRBA, reported in 17 (63.0%) patients. Two patients (7.7%) showed autoimmune complications as the first presentation of immunodeficiency. Eleven patients (40.7%) developed one type of autoimmunity, and 16 patients (59.3%) progressed to poly-autoimmunity. Most of the patients with mono-autoimmunity (n = 9, 90.0%) primarily developed infectious complications, while in patients with poly-autoimmunity, the most common first presentation was enteropathy (n = 6, 37.6%). In 13 patients (61.9%), the diagnosis of autoimmune disorders preceded the diagnosis of primary immunodeficiency. The most frequent autoimmune manifestations were hematologic (40.7%), gastrointestinal (48.1%), rheumatologic (25.9%), and dermatologic (22.2%) disorders. Patients with poly-autoimmunity had lower regulatory T cells than patients with mono-autoimmunity. Conclusion: In our cohort, the diagnosis of autoimmune disorders preceded the diagnosis of primary immunodeficiency in most patients. This association highlights the fact that patients referring with autoimmune manifestations should be evaluated for humoral immunity. © 2020 S. Karger AG, Basel. All rights reserved.
Other Related Docs
16. Common Presentations and Diagnostic Approaches, Stiehm's Immune Deficiencies: Inborn Errors of Immunity (2020)